LASP1 and prostate carcinoma: Moreover, abnormal expression of LASP1 was detected in a variety of other cancers, including hepatocellular carcinoma [13], nasopharyngeal carcinoma [11], prostate cancer [14], pancreatic cancer [15], and ovarian cancer [12].